Torrent Pharma's Credit Rating Affirmed at IND AA+(Stable); IND A1+ Assigned to Commercial Paper
Torrent Pharmaceuticals Limited announced on January 2, 2026, that India Ratings and Research Private Limited has affirmed the company's credit rating for existing banking facilities, issuer rating, a...
Limitations of AI summaries
AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.
Platforms like Prysm provide stock-level and portfolio-level analysis.
Why is Torrent Pharmaceuticals Limited in the news today?
Torrent Pharmaceuticals Limited (TORNTPHARM) is in the news due to the affirmation of a stable credit rating and assignment of a strong rating for commercial paper indicates a positive financial standing and creditworthiness of the company.
AI-Powered Summary
Market Context
Top Queries
More News
Explore Prysm Tools
Related Stories
Torrent Pharma's Credit Rating Affirmed at IND AA+(Stable); IND A1+ Assigned to Commercial Paper
January 2, 2026, 04:42 PM
Top Queries to Ask About Torrent Pharmaceuticals Limited
More Details on This News
Torrent Pharmaceuticals Limited announced on January 2, 2026, that India Ratings and Research Private Limited has affirmed the company's credit rating for existing banking facilities, issuer rating, and Non-Convertible Debentures (NCDs) at IND AA+(Stable).
Additionally, the rating agency has assigned a credit rating of IND A1+ for the company's proposed Commercial Paper.
This intimation is made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
See What Deep Dive Gives You — in Seconds
“what happens when you click
Deep Dive “
“what happens when you click Deep Dive “
Instant AI Summary - “Get clean, noise-free earnings breakdowns.”
PDF Insights - “Download detailed, AI-generated reports.”
Metrics Explained -“Key ratios & trends explained in simple language.”
Want to know if this news pushes your stock up or down?
Just tap
